Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Probiotics show promise for fatty liver in early trial

NCT ID NCT04555434

First seen Feb 23, 2026 · Last updated May 25, 2026 · Updated 13 times

Summary

This study tested whether three types of probiotics (Lactobacillus and Pediococcus strains) can improve liver health in people with non-alcoholic fatty liver disease. 89 adults took either a probiotic or a placebo daily for 8 weeks, along with a standard liver medication. Researchers measured changes in liver enzymes, gut bacteria, and liver fat to see if the probiotics helped control the disease.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON-ALCOHOLIC FATTY LIVER DISEASE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Hallym University Chuncheon Sacred Heart Hospital

    Chuncheon, Gangwon-do, 200-704, South Korea

Conditions

Explore the condition pages connected to this study.